ALOX15B | Arachidonate 15-lipoxygenase, type B | Cytoskeleton related proteins Enzymes Predicted intracellular proteins
| ![](/images_static/rna_center.gif) | ![](/images/10562/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
ALOX5 | Arachidonate 5-lipoxygenase | Enzymes FDA approved drug targets Predicted intracellular proteins
| ![](/images/5066/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/5066/13292_B_7_8_rna_selected_60x60.jpg) | Mixed |
AOC1 | Amine oxidase, copper containing 1 | Enzymes Predicted intracellular proteins Predicted secreted proteins
| ![](/images/31032/72997_A_2_7_selected_60x60.jpg) | ![](/images/31032/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/31032/72996_B_3_3_rna_selected_60x60.jpg) | Tissue enhanced |
AOC2 | Amine oxidase, copper containing 2 (retina-specific) | Enzymes Predicted secreted proteins
| ![](/images/57779/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/57779/133414_B_8_2_rna_selected_60x60.jpg) | Group enriched |
AOC3 | Amine oxidase, copper containing 3 | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/25797/57832_B_9_2_rna_selected_60x60.jpg) | Expressed in all |
AOX1 | Aldehyde oxidase 1 | Enzymes Plasma proteins Predicted intracellular proteins
| ![](/images/40215/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/40199/88099_A_2_5_rna_selected_60x60.jpg) | Tissue enhanced |
ASPDH | Aspartate dehydrogenase domain containing | Enzymes Predicted intracellular proteins
| ![](/images/42654/ihc_selected_60x60.jpg) | ![](/images/42631/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/42631/96310_B_7_1_rna_selected_60x60.jpg) | Tissue enhanced |
ASPH | Aspartate beta-hydroxylase | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| ![](/images/59303/ihc_selected_60x60.jpg) | | | ![](/images/59303/133134_B_9_8_rna_selected_60x60.jpg) | Expressed in all |
BBOX1 | Butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 | Enzymes Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/7600/21592_A_9_2_rna_selected_60x60.jpg) | Tissue enriched |
BCKDHA | Branched chain keto acid dehydrogenase E1, alpha polypeptide | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/36640/77607_B_7_2_rna_selected_60x60.jpg) | Expressed in all |
BCKDHB | Branched chain keto acid dehydrogenase E1, beta polypeptide | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted secreted proteins
| ![](/images/31580/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images/31580/ihc_cell_selected_60x60.jpg) | ![](/images/31580/69151_B_9_4_rna_selected_60x60.jpg) | Expressed in all |
BCO1 | Beta-carotene oxygenase 1 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| ![](/images/43811/ihc_selected_60x60.jpg) | ![](/images/43811/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/43811/102164_B_9_7_rna_selected_60x60.jpg) | Tissue enhanced |
BCO2 | Beta-carotene oxygenase 2 | Enzymes Predicted intracellular proteins
| ![](/images/39825/ihc_selected_60x60.jpg) | ![](/images/40695/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/39825/87632_A_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
BDH1 | 3-hydroxybutyrate dehydrogenase, type 1 | Candidate cardiovascular disease genes Enzymes Mitochondrial proteins Predicted intracellular proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/30947/72611_B_9_1_rna_selected_60x60.jpg) | Expressed in all |
BDH2 | 3-hydroxybutyrate dehydrogenase, type 2 | Enzymes Predicted intracellular proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/36029/74018_B_8_1_rna_selected_60x60.jpg) | Expressed in all |
BLVRA | Biliverdin reductase A | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| ![](/images/42865/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images/54322/129635_A_5_5_selected_60x60.jpg) | ![](/images/42865/93382_B_9_1_rna_selected_60x60.jpg) | Expressed in all |
BLVRB | Biliverdin reductase B (flavin reductase (NADPH)) | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | ![](/images/41937/90336_B_1_6_rna_selected_60x60.jpg) | Expressed in all |
C14orf169 | Chromosome 14 open reading frame 169 | Enzymes Predicted intracellular proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Expressed in all |
CAT | Catalase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | ![](/images/1515/ihc_cell_selected_60x60.jpg) | ![](/images/55838/135651_B_8_2_rna_selected_60x60.jpg) | Expressed in all |
CBR1 | Carbonyl reductase 1 | Enzymes Plasma proteins Predicted intracellular proteins
| ![](/images/18433/ihc_selected_60x60.jpg) | | | ![](/images/18433/42080_B_8_5_rna_selected_60x60.jpg) | Expressed in all |
CBR3 | Carbonyl reductase 3 | Enzymes Predicted intracellular proteins
| ![](/images/18434/ihc_selected_60x60.jpg) | | | ![](/images/18434/41449_B_9_2_rna_selected_60x60.jpg) | Mixed |
CDO1 | Cysteine dioxygenase type 1 | Enzymes Predicted intracellular proteins
| | ![](/images/36573/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/57503/137455_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
CH25H | Cholesterol 25-hydroxylase | Enzymes Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Mixed |
CHDH | Choline dehydrogenase | Enzymes Mitochondrial proteins Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/36633/81337_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
CP | Ceruloplasmin (ferroxidase) | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/1834/7614_B_7_3_rna_selected_60x60.jpg) | Tissue enriched |
CPOX | Coproporphyrinogen oxidase | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted membrane proteins
| ![](/images/15736/ihc_selected_60x60.jpg) | | | ![](/images/15736/35030_B_8_1_rna_selected_60x60.jpg) | Expressed in all |
CRYL1 | Crystallin, lambda 1 | Enzymes Plasma proteins Predicted intracellular proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/40403/86526_B_8_2_rna_selected_60x60.jpg) | Expressed in all |
CRYM | Crystallin, mu | Enzymes Predicted intracellular proteins
| ![](/images/19086/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/19086/45338_B_9_1_rna_selected_60x60.jpg) | Group enriched |
CRYZ | Crystallin, zeta (quinone reductase) | Enzymes Plasma proteins Predicted intracellular proteins
| | | | ![](/images/23290/50344_B_8_6_rna_selected_60x60.jpg) | Expressed in all |
CYB5R1 | Cytochrome b5 reductase 1 | Enzymes Predicted intracellular proteins
| | ![](/images/14147/if_selected_60x60.jpg) | | ![](/images/14147/32024_B_8_7_rna_selected_60x60.jpg) | Expressed in all |
CYB5R2 | Cytochrome b5 reductase 2 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| ![](/images/38962/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/38962/81442_B_9_5_rna_selected_60x60.jpg) | Tissue enhanced |
CYB5R3 | Cytochrome b5 reductase 3 | Cancer-related genes Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| ![](/images/1566/ihc_selected_60x60.jpg) | | | ![](/images/1566/5265_B_9_3_rna_selected_60x60.jpg) | Expressed in all |
CYB5R4 | Cytochrome b5 reductase 4 | Enzymes Predicted intracellular proteins
| ![](/images/18992/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/18992/54409_B_8_6_rna_selected_60x60.jpg) | Expressed in all |
CYB5RL | Cytochrome b5 reductase-like | Enzymes Predicted intracellular proteins
| ![](/images/42671/ihc_selected_60x60.jpg) | | ![](/images/42671/ihc_cell_selected_60x60.jpg) | ![](/images/42671/118579_B_9_8_rna_selected_60x60.jpg) | Mixed |
CYP11A1 | Cytochrome P450, family 11, subfamily A, polypeptide 1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/16436/142443_B_8_5_rna_selected_60x60.jpg) | Tissue enriched |
CYP11B1 | Cytochrome P450, family 11, subfamily B, polypeptide 1 | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/49171/142129_B_8_2_rna_selected_60x60.jpg) | Tissue enriched |
CYP11B2 | Cytochrome P450, family 11, subfamily B, polypeptide 2 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/49171/142129_B_8_1_rna_selected_60x60.jpg) | Tissue enriched |
CYP17A1 | Cytochrome P450, family 17, subfamily A, polypeptide 1 | Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/48533/142448_B_7_3_rna_selected_60x60.jpg) | Tissue enriched |
CYP19A1 | Cytochrome P450, family 19, subfamily A, polypeptide 1 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins
| | ![](/images/51194/1332_D4_2_selected_60x60.jpg) | ![](/images/51194/ihc_cell_selected_60x60.jpg) | ![](/images/355/2188_B_7_4_rna_selected_60x60.jpg) | Tissue enriched |
CYP1A1 | Cytochrome P450, family 1, subfamily A, polypeptide 1 | Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| ![](/images/18654/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/18654/41747_B_9_1_rna_selected_60x60.jpg) | Group enriched |
CYP1A2 | Cytochrome P450, family 1, subfamily A, polypeptide 2 | Cancer-related genes Enzymes Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images/16531/ihc_cell_selected_60x60.jpg) | ![](/images/16531/36094_B_8_5_rna_selected_60x60.jpg) | Tissue enriched |
CYP1B1 | Cytochrome P450, family 1, subfamily B, polypeptide 1 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/11705/33104_B_8_6_rna_selected_60x60.jpg) | Mixed |
CYP21A2 | Cytochrome P450, family 21, subfamily A, polypeptide 2 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/48979/ihc_cell_selected_60x60.jpg) | ![](/images/48979/114250_B_8_3_rna_selected_60x60.jpg) | Tissue enriched |
CYP24A1 | Cytochrome P450, family 24, subfamily A, polypeptide 1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/22261/158690_A_2_8_rna_selected_60x60.jpg) | Tissue enhanced |
CYP27A1 | Cytochrome P450, family 27, subfamily A, polypeptide 1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| ![](/images/59155/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/59155/141443_B_9_4_rna_selected_60x60.jpg) | Expressed in all |
CYP27B1 | Cytochrome P450, family 27, subfamily B, polypeptide 1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| ![](/images_static/rna_center.gif) | ![](/images/43358/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
CYP2A13 | Cytochrome P450, family 2, subfamily A, polypeptide 13 | Enzymes Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/46713/114685_B_8_2_rna_selected_60x60.jpg) | Tissue enriched |
CYP2A7 | Cytochrome P450, family 2, subfamily A, polypeptide 7 | Enzymes Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/33510/ihc_cell_selected_60x60.jpg) | ![](/images/33510/66382_B_8_2_rna_selected_60x60.jpg) | Tissue enriched |
CYP2C18 | Cytochrome P450, family 2, subfamily C, polypeptide 18 | Enzymes Plasma proteins Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
CYP2C19 | Cytochrome P450, family 2, subfamily C, polypeptide 19 | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/15066/34421_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |